| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |